HKSE:2552
Hua Medicine (Shanghai) Ltd. · HKSE · Healthcare · HKD · FY for 2025
Figures on this page computed 2026-11-08 13:40 UTC
Last close
n/aHKD
Market data
1.7xP/E
Price / Earnings per Share (diluted)
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
n/mNet marginnet income exceeds revenue
Net income exceeds revenue.
Net Income / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
-12.1%FCF margin
Free Cash Flow / Revenue x 100
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDebt/equity
We do not hold this figure for this company, so there is nothing to place.
Total Debt / Shareholders' Equity
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
- Source
- computed
- Taken on
- 2026-11-08
- Reported in
- HKD
- computed
5 of 6 traits placed on the market's range. Nothing sits below its sector's middle.
- Growth124.4%97 of 100, above its sector
- Returns on capital109.9%99 of 100, above its sector
- Margins56.9%41 of 100, at its sector
- Price1.7x57 of 100, above its sector
- Safety6.1752 of 100, at its sector
- What it pays outn/anot placed
- What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.
Ten years as a story
lens 9 of 9We hold no filed year for this company, so there is nothing to read.
Nothing is drawn in its place. The other lenses are unaffected.